{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:31:53Z","timestamp":1778315513414,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"am","delay-in-days":311,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.neulet.2019.03.038","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T12:17:49Z","timestamp":1553861869000},"page":"100-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Association of variants of prodynorphin promoter 68-bp repeats in caucasians with opioid dependence diagnosis: Effect on age trajectory of heroin use"],"prefix":"10.1016","volume":"704","author":[{"given":"Vadim","family":"Yuferov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3093-5141","authenticated-orcid":false,"given":"Matthew","family":"Randesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo R","family":"Butelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"van den Brink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Blanken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan M","family":"van Ree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrg","family":"Ott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Jeanne","family":"Kreek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2019.03.038_bib0005","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2012.05.005","article-title":"Kappa-opioid receptor\/dynorphin system: genetic and pharmacotherapeutic implications for addiction","volume":"35","author":"Butelman","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neulet.2019.03.038_bib0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/npp.2015.258","article-title":"Dynorphin, dysphoria, and dependence: the stress of addiction","volume":"41","author":"Chavkin","year":"2016","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.neulet.2019.03.038_bib0015","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nn1583","article-title":"Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction","volume":"8","author":"Kreek","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neulet.2019.03.038_bib0020","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-3565(25)24578-5","article-title":"Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats","volume":"244","author":"Di Chiara","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2019.03.038_bib0025","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00213-003-1688-3","article-title":"Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL\/6J mice","volume":"172","author":"Zhang","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neulet.2019.03.038_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.57.1.1","article-title":"Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments","volume":"57","author":"Kreek","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neulet.2019.03.038_bib0035","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00439-012-1172-4","article-title":"The genetics of the opioid system and specific drug addictions","volume":"131","author":"Levran","year":"2012","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neulet.2019.03.038_bib0040","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1471-4159.2000.740472.x","article-title":"An allelic variation in the human prodynorphin gene promoter alters stimulus-induced expression","volume":"74","author":"Zimprich","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2019.03.038_bib0045","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1369-1600.2010.00248.x","article-title":"Cell-specific effects of variants of the 68-base pair tandem repeat on prodynorphin gene promoter activity","volume":"16","author":"Rouault","year":"2011","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neulet.2019.03.038_bib0050","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/molbev\/msp276","article-title":"Multiple functional variants in cis modulate PDYN expression","volume":"27","author":"Babbitt","year":"2010","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.neulet.2019.03.038_bib0055","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1369-1600.2007.00069.x","article-title":"Prodynorphin gene promoter repeat associated with cocaine\/alcohol codependence","volume":"12","author":"Williams","year":"2007","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neulet.2019.03.038_bib0060","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2147\/NDT.S159954","article-title":"Gender-specific association of functional prodynorphin 68 bp repeats with cannabis exposure in an African American cohort","volume":"14","author":"Yuferov","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neulet.2019.03.038_bib0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ajmg.b.30238","article-title":"Confirmation of the association between a polymorphism in the promoter region of the prodynorphin gene and cocaine dependence","volume":"139B","author":"Dahl","year":"2005","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neulet.2019.03.038_bib0070","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.brainresbull.2011.02.010","article-title":"Association between heroin dependence and prodynorphin gene polymorphisms","volume":"85","author":"Wei","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neulet.2019.03.038_bib0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neulet.2018.08.023","article-title":"Genetic association analyses and meta-analysis of Dynorphin-Kappa Opioid system potential functional variants with heroin dependence","volume":"685","author":"Yuanyuan","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2019.03.038_bib0080","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.psychres.2014.06.048","article-title":"Association between VNTR polymorphism in promoter region of prodynorphin (PDYN) gene and heroin dependence","volume":"219","author":"Saify","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neulet.2019.03.038_bib0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00041444-200512000-00013","article-title":"A functional prodynorphin promoter polymorphism and opioid dependence","volume":"15","author":"Ray","year":"2005","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.neulet.2019.03.038_bib0090","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1073\/pnas.0710902105","article-title":"Opioid neuropeptide genotypes in relation to heroin abuse: dopamine tone contributes to reversed mesolimbic proenkephalin expression","volume":"105","author":"Nikoshkov","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neulet.2019.03.038_bib0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2217\/pgs-2017-0134","article-title":"Dopamine gene variants in opioid addiction: comparison of dependent patients, nondependent users and healthy controls","volume":"19","author":"Randesi","year":"2018","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.neulet.2019.03.038_bib0100","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fgene.2018.00450","article-title":"Methadone dosage and plasma levels, SNPs of OPRM1 gene and age of first drug use were associated with outcomes of methadone maintenance treatment","volume":"9","author":"Peng","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.neulet.2019.03.038_bib0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.drugalcdep.2014.09.783","article-title":"Personality as a risk factor for illicit opioid use and a protective factor for illicit opioid dependence","volume":"145","author":"Zaaijer","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"Suppl 2","key":"10.1016\/j.neulet.2019.03.038_bib0110","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0924-977X(10)70001-8","article-title":"Heroin-assisted treatment in the Netherlands: History, findings, and international context","volume":"20","author":"Blanken","year":"2010","journal-title":"Eur. neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol"},{"key":"10.1016\/j.neulet.2019.03.038_bib0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0376-8716(02)00308-3","article-title":"The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications","volume":"69","author":"Kellogg","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neulet.2019.03.038_bib0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.drugalcdep.2018.05.028","article-title":"Re-evaluation of the KMSK scales, rapid dimensional measures of self-exposure to specific drugs: gender-specific features","volume":"190","author":"Butelman","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neulet.2019.03.038_bib0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1369-1600.2010.00265.x","article-title":"A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women","volume":"17","author":"Crystal","year":"2012","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neulet.2019.03.038_bib0130","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/genetics\/155.2.945","article-title":"Inference of population structure using multilocus genotype data","volume":"155","author":"Pritchard","year":"2000","journal-title":"Genetics"},{"key":"10.1016\/j.neulet.2019.03.038_bib0135","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1176\/appi.ajp.2009.08071068","article-title":"Association of substance use disorders with childhood trauma but not African genetic heritage in an African American cohort","volume":"166","author":"Ducci","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2019.03.038_bib0140","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neulet.2019.03.038_bib0145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drugalcdep.2016.08.634","article-title":"Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence","volume":"168","author":"Randesi","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neulet.2019.03.038_bib0150","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1037\/abn0000191","article-title":"Age at first use and later substance use disorder: shared genetic and environmental pathways for nicotine, alcohol, and Cannabis","volume":"125","author":"Richmond-Rakerd","year":"2016","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.neulet.2019.03.038_bib0155","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/j.1360-0443.2009.02648.x","article-title":"Timing of first alcohol use and alcohol dependence: evidence of common genetic influences","volume":"104","author":"Sartor","year":"2009","journal-title":"Addict. (Abingdon, Engl.)"},{"key":"10.1016\/j.neulet.2019.03.038_bib0160","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1530-0277.2009.01044.x","article-title":"Evidence for an interaction between age at first drink and genetic influences on DSM-IV alcohol dependence symptoms, Alcoholism","volume":"33","author":"Agrawal","year":"2009","journal-title":"Clin. Exp. Res."},{"key":"10.1016\/j.neulet.2019.03.038_bib0165","doi-asserted-by":"crossref","first-page":"19384","DOI":"10.1523\/JNEUROSCI.1979-13.2013","article-title":"Long-term antagonism of kappa opioid receptors prevents escalation of and increased motivation for heroin intake","volume":"33","author":"Schlosburg","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.03.038_bib0170","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00213-005-0167-4","article-title":"Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats","volume":"183","author":"Beardsley","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neulet.2019.03.038_bib0175","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbr.2018.11.006","article-title":"Kappa opioid receptors mediate yohimbine-induced increases in impulsivity in the 5-choice serial reaction time task","volume":"359","author":"Funk","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2019.03.038_bib0180","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1038\/npp.2013.129","article-title":"Dissociable effects of kappa-opioid receptor activation on impulsive phenotypes in wistar rats","volume":"38","author":"Walker","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2019.03.038_bib0185","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1360-0443.2009.02754.x","article-title":"Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands","volume":"105","author":"Blanken","year":"2010","journal-title":"Addict. (Abingdon, Engl.)"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019302022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019302022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:25:47Z","timestamp":1759609547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394019302022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":37,"alternative-id":["S0304394019302022"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2019.03.038","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of variants of prodynorphin promoter 68-bp repeats in caucasians with opioid dependence diagnosis: Effect on age trajectory of heroin use","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2019.03.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}